Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism GSPT1 modulators(G1 to S phase transition 1 modulators), GSPT2 modulators(Eukaryotic peptide chain release ERF3B modulators), PLK1 modulators(Polo like kinase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal Neoplasms | Preclinical | DE | 01 Feb 2022 |